Item 5. Market for Registrant’s Common Equity
ITEM
5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market
Information and Holders of Common Stock
Our
common stock is listed on the NYSE American, under the symbol “NRXS”.
As
of March 13, 2025, there were approximately 682 record holders of our common stock. The number of record holders does not include beneficial
owners of common stock whose shares are held in the names of banks, brokers, nominees or other fiduciaries and holders of unissued shares
common stock.
The
last reported sales price for our Common Stock as reported on the NYSE American on March 13, 2025 was $2.10.
Dividends
We
have not declared or paid any cash dividends on our common stock, and we do not anticipate declaring or paying cash dividends for the
foreseeable future. We are not subject to any legal restrictions respecting the payment of dividends, except that we may not pay dividends
if the payment would render us insolvent. Any future determination as to the payment of cash dividends on our common stock will be at
the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements and other
factors that the board of directors considers to be relevant.
Recent
Sales of Unregistered Securities
On
November 14, 2024, the Company entered into security purchase agreements with five accredited investors for the issuance and purchase
of 45,653 shares of the Company’s Series B Preferred Stock, par value $0.001 per share, for an aggregate purchase price
of $108,664.
On
December 26, 2024, the Company issued 10,000 shares of common stock to an accredited investor for their services in bringing RED to
market.
On
January 3, 2025 and March 6, 2025, the Company granted 360,902 and 373,275 restricted stock units (RSUs), respectively, to certain
employees pursuant to the 2022 NeurAxis, Inc. Omnibus Securities and Incentive Plan, as amended on August 15, 2024. The RSUs
vest annually over a three-year cliff-vesting period and are payable in shares of the Company’s common stock. The RSUs fully
vest upon (i) death or disability or (ii) change of control. Dividend equivalents accrue on RSUs and are paid upon
vesting.
On
January 17, 2025, the Company issued (i) 39,471 shares of common stock to its independent board members for their service from April
1, 2024 through December 31, 2024 and (ii) 186,166 shares of common stock to an accredited investor upon conversion of 502,647
common stock warrants in a cash less exercise transaction.
ITEM
6. RESERVED
64
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.